ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.337,51
0,37%
S&P 500
6.080,46
-0,10%
Dow Jones
44.242,28
0,19%
Euro vs US Dollar
1,04138
0,05%
Bitcoin
104.321,83
0,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Inhibrx Biosciences Inc (INBX) Börsenkurse

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

NASDAQ
13,60
-0,59
(-4,16%)
Geschlossen 23 Januar 10:00PM
Verzögert um 15 Minuten
13,60
0,00
( 0,00% )
Vor Marktöffnung: 3:09PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
13,60
Gebot
13,60
Fragen
17,54
Volumen
238
0,00 Tagesbereich 0,00
10,80 52-Wochen-Bereich 39,79
Marktkapitalisierung
196,872M
Handelsende
13,60
Handelsbeginn
-
Letzte Trade
3
@
13.81
Letzter Handelszeitpunkt
15:09:34
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
76.275
Ausgegebene Aktien
14.475.904
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,27
Gewinn pro Aktie (EPS)
-10,71
Erlöse
1,63M
Nettogewinn
-154,96M

Über Inhibrx Biosciences Inc

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.inhibrx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was US$13,60. Over the last year, Inhibrx Biosciences shares have traded in a share price range of US$ 10,80 to US$ 39,79.

Inhibrx Biosciences currently has 14.475.904 shares in issue. The market capitalisation of Inhibrx Biosciences is US$196,87 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.27.

INBX Neueste Nachrichten

Weitere Nachrichten

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer PR Newswire SAN DIEGO, Jan. 21, 2025 SAN DIEGO, Jan. 21, 2025...

21 Januar 2025
PR Newswire (US)

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance PR Newswire SAN DIEGO, Jan. 13, 2025 SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. ("Inhibrx" or the...

13 Januar 2025
PR Newswire (US)

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

14 November 2024
PR Newswire (US)

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

04 November 2024
PR Newswire (US)

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

14 August 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

31 Mai 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

31 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Mai 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.040.29498525073713.5614.8613.127819013.70630098CS
4-0.81-5.6210964607914.4116.8312.517156814.33634625CS
12-2.72-16.666666666716.3217.4112.257627514.71967264CS
260.261.9490254872613.3417.7910.88632614.72961186CS
52-21.9-61.690140845135.539.7910.834772530.95573291CS
156-13.5-49.81549815527.139.797.6742304224.93965258CS
260-6.1-30.964467005119.750.977.6733819025.8290078CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?
The current share price of Inhibrx Biosciences is US$ 13,60
How many Inhibrx Biosciences shares are in issue?
Inhibrx Biosciences has 14.475.904 shares in issue
What is the market cap of Inhibrx Biosciences?
The market capitalisation of Inhibrx Biosciences is USD 196,87M
What is the 1 year trading range for Inhibrx Biosciences share price?
Inhibrx Biosciences has traded in the range of US$ 10,80 to US$ 39,79 during the past year
What is the PE ratio of Inhibrx Biosciences?
The price to earnings ratio of Inhibrx Biosciences is -1,27
What is the cash to sales ratio of Inhibrx Biosciences?
The cash to sales ratio of Inhibrx Biosciences is 120,46
What is the reporting currency for Inhibrx Biosciences?
Inhibrx Biosciences reports financial results in USD
What is the latest annual turnover for Inhibrx Biosciences?
The latest annual turnover of Inhibrx Biosciences is USD 1,63M
What is the latest annual profit for Inhibrx Biosciences?
The latest annual profit of Inhibrx Biosciences is USD -154,96M
What is the registered address of Inhibrx Biosciences?
The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Inhibrx Biosciences website address?
The website address for Inhibrx Biosciences is www.inhibrx.com
Which industry sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AALAmerican Airlines Group Inc
US$ 18,66
(0,00%)
10,02M
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,58
(0,00%)
0
AADIAadi Bioscience Inc
US$ 2,99
(0,00%)
206
AACGATA Creativity Global
US$ 0,8888
(0,00%)
101
AALAmerican Airlines Group Inc
US$ 18,66
(0,00%)
10,02M
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,58
(0,00%)
0
AADIAadi Bioscience Inc
US$ 2,99
(0,00%)
206
AACGATA Creativity Global
US$ 0,8888
(0,00%)
101
HEPAHepion Pharmaceuticals Inc
US$ 0,135
(0,00%)
111,68M
QNRXQuoin Pharmaceuticals Ltd
US$ 0,5896
(0,00%)
37,25M
KOPNKopin Corporation
US$ 1,47
(0,00%)
28,49M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,319
(0,00%)
15,72M
VIGLVigil Neuroscience Inc
US$ 2,03
(0,00%)
14,35M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
INBX
Inhibrx Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten